Desiree J. Wendering
Carl Neuberg Str. 1
Hannover, NI 30625, Germany
Hannover, NI 30625, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulation.
Journal: Molecular therapy. Advances
Published: December 12, 2025
Effector memory-type regulatory T cells display phenotypic and functional instability.
Journal: Science advances
Published: September 04, 2024
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients.
Journal: Molecular therapy. Methods & clinical development
Published: February 16, 2022
HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.
Journal: Frontiers in immunology
Published: September 18, 2020
CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 23, 2020
The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer.
Journal: Science translational medicine
Published: February 19, 2020
Comprehensive Characterization of a Next-Generation Antiviral T-Cell Product and Feasibility for Application in Immunosuppressed Transplant Patients.
Journal: Frontiers in immunology
Published: January 08, 2019
The Value of a Rapid Test of Human Regulatory T Cell Function Needs to be Revised.
Journal: Frontiers in immunology
Published: November 01, 2018
High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population.
Journal: Nature medicine
Published: March 11, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026